GPNMB and Parkinson disease: Five genes including CD38, GPNMB, RAB29, TMEM175, and TTC19 demonstrated significant associations with PD on both protein and mRNA level, suggesting that these genes are promising therapeutic targets with their gene-regulated expression and protein abundance together significantly correlated with PD.